Dysregulated mineral metabolism in children with chronic kidney disease

Current Opinion in Nephrology and Hypertension

Volumn 20, Issue 3, 2011, Pages 233-240

  Shroff, Rukshana ^a  

^a Renal Unit   (United Kingdom)

Author keywords

chronic kidney disease; fibroblast growth factor 23; hyperparathyroidism; vascular calcification; vitamin D

Indexed keywords

CALCIUM; FIBROBLAST GROWTH FACTOR 23; PARATHYROID HORMONE; PHOSPHORUS; VITAMIN D;

BLOOD VESSEL CALCIFICATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; DIALYSIS; HUMAN; HYPERCALCEMIA; HYPERPARATHYROIDISM; HYPERPHOSPHATEMIA; KIDNEY TRANSPLANTATION; METABOLIC DISORDER; MINERAL METABOLISM DYSFUNCTION; PRIORITY JOURNAL; REVIEW; UREMIA;

CALCINOSIS; CARDIOVASCULAR DISEASES; CHILD; CHRONIC DISEASE; FIBROBLAST GROWTH FACTORS; HUMANS; HYPERCALCEMIA; HYPERPARATHYROIDISM; HYPERPHOSPHATEMIA; KIDNEY DISEASES; MINERALS; UREMIA; VASCULAR DISEASES; VITAMIN D;

EID: 79954990279     PISSN: 10624821     EISSN: 14736543     Source Type: Journal    
DOI: 10.1097/MNH.0b013e3283455e8c     Document Type: Review

References (50)

1. Chavers BM, Li S, Collins AJ, Herzog CA. Cardiovascular disease in pediatric chronic dialysis patients. Kidney Int 2002; 62:648-653. (Pubitemid 34784616)
2. McDonald SP, Craig JC. Long-term survival of children with end-stage renal disease. N Engl J Med 2004; 350:2654-2662. (Pubitemid 38788000)
3. Parekh RS, Carroll CE, Wolfe RA, Port FK. Cardiovascular mortality in children and young adults with end-stage kidney disease. J Pediatr 2002; 141:191-197.
4. Moe S, Drueke T, Cunningham J, et al. Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease Improving Global Outcomes (KDIGO). Kidney Int 2006; 69:1945-1953. (Pubitemid 43924257)
5. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998; 32:S112-S119. (Pubitemid 28527268)
6. Groothoff JW, Gruppen MP, Offringa M, et al. Mortality and causes of death of end-stage renal disease in children: a Dutch cohort study. Kidney Int 2002; 61:621-629. (Pubitemid 34102605)
7. Oh J, Wunsch R, Turzer M, et al. Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation 2002; 106:100-105. (Pubitemid 34747448)
8. Civilibal M, Caliskan S, Kurugoglu S, et al. Progression of coronary calcification in pediatric chronic kidney disease stage 5. Pediatr Nephrol 2009; 24:555-563.
9. Litwin M, Wuhl E, Jourdan C, et al. Evolution of large-vessel arteriopathy in paediatric patients with chronic kidney disease. Nephrol Dial Transplant 2008; 23:2552-2557.
10. Kavey RE, Allada V, Daniels SR, et al. Cardiovascular risk reduction in highrisk pediatric patients: a scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group onQuality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation 2006; 114:2710-2738.
11. Levey AS, Beto JA, Coronado BE, et al. Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease. Am J Kidney Dis 1998; 32:853-906. (Pubitemid 28516321)
12. Litwin M, Wuhl E, Jourdan C, et al. Altered morphologic properties of large arteries in children with chronic renal failure and after renal transplantation. J Am Soc Nephrol 2005; 16:1494-1500. (Pubitemid 41716535)
13. Mitsnefes MM, Daniels SR, Schwartz SM, et al. Severe left ventricular hypertrophy in pediatric dialysis: prevalence and predictors. Pediatr Nephrol 2000; 14:898-902. (Pubitemid 30621296)
14. Mitsnefes M, Stablein D. Hypertension in pediatric patients on long-term dialysis: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Am J Kidney Dis 2005; 45:309-315. (Pubitemid 40431057)
15. Block GA, Hulbert-Shearon TE, Levin NW, Port FK. Association of serum phosphorus and calcium- phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 1998; 31:607-617.
16. Civilibal M, Caliskan S, Adaletli I, et al. Coronary artery calcifications in children with end-stage renal disease. Pediatr Nephrol 2006; 21:1426-1433. (Pubitemid 44283475)
17. Goodman WG, Goldin J, Kuizon BD, et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 2000; 342:1478-1483. (Pubitemid 30318271)
18. Mitsnefes MM, Kimball TR, Kartal J, et al. Cardiac and vascular adaptation in pediatric patients with chronic kidney disease: role of calcium-phosphorus metabolism. J Am Soc Nephrol 2005; 16:2796-2803.
19. Shroff R, Donald A, Hiorns M, et al. Mineral metabolism and vascular damage in children on dialysis. J Am Soc Nephrol 2007; 18:2996-3003. (Pubitemid 350058407)
20. Covic A, Mardare N, Gusbeth-Tatomir P, et al. Increased arterial stiffness in children on haemodialysis. Nephrol Dial Transplant 2006; 21:729-735. (Pubitemid 43372922)
21. Kis E, Cseprekal O, Biro E, et al. Effects of bone and mineral metabolism on arterial elasticity in chronic renal failure. Pediatr Nephrol 2009; 24:2413-2420.
22. Briese S, Wiesner S, Will JC, et al. Arterial and cardiac disease in young adults with childhood-onset end-stage renal disease-impact of calcium and vitamin D therapy. Nephrol Dial Transplant 2006; 21:1906-1914. (Pubitemid 43985719)
23. Civilibal M, Caliskan S, Oflaz H, et al. Traditional and 'new' cardiovascular risk markers and factors in pediatric dialysis patients. Pediatr Nephrol 2007; 22:1021-1029. (Pubitemid 46881922)
24. Giachelli CM. Vascular calcification: in vitro evidence for the role of inorganic phosphate. J Am Soc Nephrol 2003; 14:S300-S304. (Pubitemid 37052394)
25. Shroff RC, Shanahan CM. The vascular biology of calcification. Semin Dial 2007; 20:103-109.
26. Kalantar-Zadeh K, Kuwae N, Regidor DL, et al. Survival predictability of timevarying indicators of bone disease in maintenance hemodialysis patients. Kidney Int 2006; 70:771-780. (Pubitemid 44215354)
27. Rees L. What parathyroid hormone levels should we aim for in children with stage 5 chronic kidney disease; what is the evidence? Pediatr Nephrol 2008; 23:179-184.
28. Shroff R, Egerton M, Bridel M, et al. A bimodal association of vitamin D levels and vascular disease in children on dialysis. J Am Soc Nephrol 2008; 19:1239-1246.
29. Teng M, Wolf M, Lowrie E, et al. Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy. N Engl J Med 2003; 349:446-456. (Pubitemid 36910023)
30. Tentori F, Hunt WC, Stidley CA, et al. Mortality risk among hemodialysis patients receiving different vitamin D analogs. Kidney Int 2006; 70:1858-1865. (Pubitemid 44684819)
31. Wolf M, Shah A, Gutierrez O, et al. Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int 2007; 72:1004-1013. (Pubitemid 47530570)
32. Sprague SM, Llach F, Amdahl M, et al. Paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidism. Kidney Int 2003; 63:1483-1490. (Pubitemid 36350014)
33. Gutierrez OM, Januzzi JL, Isakova T, et al. Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease. Circulation 2009; 119: 2545-2552.
34. Gutierrez OM, Mannstadt M, Isakova T, et al. Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med 2008; 359:584-592.
35. Van Husen M, Fischer AK, Lehnhardt A, et al. Fibroblast growth factor 23 and bone metabolism in children with chronic kidney disease. Kidney Int 2010; 78:200-206.
36. Wesseling-Perry K, Pereira RC, Wang H, et al. Relationship between plasma fibroblast growth factor-23 concentration and bone mineralization in children with renal failure on peritoneal dialysis. J Clin Endocrinol Metab 2009; 94:511-517.
37. Pecoits-Filho R, Sylvestre LC, Stenvinkel P. Chronic kidney disease and inflammation in pediatric patients: from bench to playground. Pediatr Nephrol 2005; 20:714-720. (Pubitemid 40663151)
38. Bakkaloglu S, Saygili A, Sever L, et al. Assessment of cardiovascular risk in paediatric peritoneal dialysis patients: a Turkish Peritoneal Dialysis Study Group (TUPEPD) report. Nephrol Dial Transplant 2009; 24:3525-3532.
39. Srivaths PR, Silverstein DM, Leung J, et al. Malnutrition-inflammation- coronary calcification in pediatric patients receiving chronic hemodialysis. Hemodial Int 2010; 14:263-269.
40. Shroff RC, McNair R, Figg N, et al. Dialysis accelerates medial vascular calcification in part by triggering smooth muscle cell apoptosis. Circulation 2008; 118:1748-1757.
41. Shroff R, Knott C, Rees L. The virtues of vitamin D - but how much is too much? Pediatr Nephrol 2010; 25:1607-1620.
42. Mitsnefes MM, Kimball TR, Witt SA, et al. Abnormal carotid artery structure and function in children and adolescents with successful renal transplantation. Circulation 2004; 110:97-101. (Pubitemid 38880140)
43. Shroff RC, Shah V, Hiorns MP, et al. The circulating calcification inhibitors, fetuin-A and osteoprotegerin, but not matrix Gla protein, are associated with vascular stiffness and calcification in children on dialysis. Nephrol Dial Transplant 2008; 23:3263-3271.
44. van Summeren MJ, Hameleers JM, Schurgers LJ, et al. Circulating calcification inhibitors and vascular properties in children after renal transplantation. Pediatr Nephrol 2008; 23:985-993.
45. Reynolds JL, Skepper JN, McNair R, et al. Multifunctional roles for serum protein fetuin-A in inhibition of human vascular smooth muscle cell calcification. J Am Soc Nephrol 2005; 16:2920-2930. (Pubitemid 44743490)
46. Krmar RT, Balzano R, Jogestrand T, et al. Prospective analysis of carotid arterial wall structure in pediatric renal transplants with ambulatory normotension and in treated hypertensive recipients. Pediatr Transplant 2008; 12:412-419. (Pubitemid 351681494)
47. Mitsnefes MM. Understanding carotid artery intima-media thickness in childhood: lessons from studies in children with renal transplants. Pediatr Transplant 2008; 12:377-380. (Pubitemid 351681495)
48. Querfeld U, Anarat A, Bayazit AK, et al. The cardiovascular comorbidity in children with chronic kidney disease (4C) study: objectives, design, and methodology. Clin J Am Soc Nephrol 2010; 5:1642-1648.
49. Furth SL, Cole SR, Moxey-Mims M, et al. Design and methods of the Chronic Kidney Disease in Children (CKiD) Prospective Cohort Study. Clin J Am Soc Nephrol 2006; 1:1006-1015.
50. Shroff RC, McNair R, Skepper JN, et al. Chronic mineral dysregulation promotes vascular smooth muscle cell adaptation and extracellular matrix calcification. J Am Soc Nephrol 2010; 21:103-112.